Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
April 15, 2024
A novel, proof-of-concept radiofrequency renal denervation strategy to improve procedural efficiency: 12-month results from the SPYRAL DYSTAL pilot study
Andrew S P Sharp, David E Kandzari, Raymond R Townsend, et al.
The American Journal of Cardiology
|
August 29, 2003
Late incomplete apposition with excessive remodeling of the stented coronary artery following intravascular brachytherapy
Hiroyuki Okura, David P Lee, Sydney Lo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 14, 2017
Plasma Tenofovir Levels to Support Adherence to TDF/FTC Preexposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California
Raphael J Landovitz, Matthew Beymer, Ryan Kofron, et al.
Circulation
|
March 20, 2016
Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study
Ian T Meredith, Jean-François Tanguay, Dean J Kereiakes, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 3, 2021
Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF
David E Kandzari, Raymond R Townsend, George Bakris, et al.
Igie : Innovation, Investigation and Insights
|
February 6, 2026
Clinical safety of a novel over-the-scope gastroduodenal full-thickness resection device for the treatment of upper GI tract lesions: a multicenter experience
Alyssa Y Choi, Peter H Nguyen, Jaehyun Kim, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
July 19, 2022
Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial
Michael A Weber, Roland E Schmieder, David E Kandzari, et al.
JACC. Cardiovascular Interventions
|
October 24, 2015
Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy
Dean J Kereiakes, Robert W Yeh, Joseph M Massaro, et al.
JAMA
|
March 18, 2015
Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial
Dean J Kereiakes, Robert W Yeh, Joseph M Massaro, et al.
European Heart Journal
|
November 18, 2014
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial
David E Kandzari, Deepak L Bhatt, Sandeep Brar, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
April 15, 2024
A novel, proof-of-concept radiofrequency renal denervation strategy to improve procedural efficiency: 12-month results from the SPYRAL DYSTAL pilot study
Andrew S P Sharp, David E Kandzari, Raymond R Townsend, et al.
The American Journal of Cardiology
|
August 29, 2003
Late incomplete apposition with excessive remodeling of the stented coronary artery following intravascular brachytherapy
Hiroyuki Okura, David P Lee, Sydney Lo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 14, 2017
Plasma Tenofovir Levels to Support Adherence to TDF/FTC Preexposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California
Raphael J Landovitz, Matthew Beymer, Ryan Kofron, et al.
Circulation
|
March 20, 2016
Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study
Ian T Meredith, Jean-François Tanguay, Dean J Kereiakes, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 3, 2021
Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF
David E Kandzari, Raymond R Townsend, George Bakris, et al.
Igie : Innovation, Investigation and Insights
|
February 6, 2026
Clinical safety of a novel over-the-scope gastroduodenal full-thickness resection device for the treatment of upper GI tract lesions: a multicenter experience
Alyssa Y Choi, Peter H Nguyen, Jaehyun Kim, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
July 19, 2022
Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial
Michael A Weber, Roland E Schmieder, David E Kandzari, et al.
JACC. Cardiovascular Interventions
|
October 24, 2015
Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy
Dean J Kereiakes, Robert W Yeh, Joseph M Massaro, et al.
JAMA
|
March 18, 2015
Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial
Dean J Kereiakes, Robert W Yeh, Joseph M Massaro, et al.
European Heart Journal
|
November 18, 2014
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial
David E Kandzari, Deepak L Bhatt, Sandeep Brar, et al.
Page
of 8